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Toll-Like Receptor 3 Increases Allergic and Irritant
Contact Dermatitis
Naomi Nakamura1,3, Risa Tamagawa-Mineoka1,3, Mayumi Ueta2, Shigeru Kinoshita2 and Norito Katoh1
There is increasing recognition of the role of Toll-like receptor 3 (TLR3) in noninfectious inflammatory diseases,
but the function of TLR3 in inflammatory skin diseases is unclear. We investigated the functions of TLR3 in allergic
and irritant contact dermatitis (ICD). The contact hypersensitivity (CHS) response was lower in Toll-like receptor 3
knockout (Tlr3 KO) mice, and was greater in TLR3 transgenic (Tg) mice than in wild-type (WT) mice after challenge
with 2,4,6-trinitro-1-chlorobenzene. Adoptive transfer of immunized lymph node cells from Tlr3 KO mice induced
CHS in WT recipients. In contrast, adoptive transfer of those from WTmice did not fully induce CHS in Tlr3 KO
recipients. The ICD reaction following croton oil application was lower in Tlr3 KO mice, and was greater in TLR3
Tg mice than in WTmice. Maturation, migration, and antigen presentation of dendritic cells and proliferation of
lymphocytes between WT mice and Tlr3 KO mice were comparable. These results show that TLR3 enhances
antigen-independent skin inflammation in the elicitation phase of allergic contact dermatitis and in ICD.
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INTRODUCTION
The innate immune system is the first line of defense against
pathogens. This system recognizes pathogens based on patho-
gen-associated molecular patterns (Ishii and Akira, 2008;
Kawai and Akira, 2011). The mammalian pattern-recognition
receptors that are responsible for this process are known as
Toll-like receptors (TLRs). The TLR family consists of at least
11 members, and is expressed on immune cells such as
macrophages, dendritic cells, granulocytes, natural killer cells,
and T cells, as well as nonimmune cells such as fibroblasts
and epithelial cells (Ishii and Akira, 2008; Kawai and Akira,
2011). Signaling through TLRs results in the activation of
nuclear factor-kB, interferon-regulatory factor, and their target
genes, and the coordinated activation of several transcription
factors regulates the expression of antimicrobial genes,
cytokines, and costimulatory molecules (Ishii and Akira,
2008; Kawai and Akira, 2011). These innate immune
responses then help prime subsequent adaptive immune
responses to the pathogens.
TLR3 recognizes viral double-stranded RNA and polyinosi-
nic:polycytidylic acid (Poly(I:C)), a mimic of double-stranded
RNA, leading to immune responses that are characterized by
the production of type I interferons and proinflammatory
cytokines (Ishii and Akira, 2008; Kawai and Akira, 2011). It
has been shown that TLR3 has roles not only in viral infection
but also in noninfectious inflammatory responses in allergic
disorders (Fransson et al., 2005; Prescott et al., 2008; Ueta
et al., 2009; Nuolivirta et al., 2012) and skin injury (Lai et al.,
2009). We have found that TLR3 enhances eosinophil
infiltration in experimental allergic conjunctivitis (Ueta et al.,
2009). Nuolivirta et al. (2012) have shown that virus-induced
asthma exacerbations are associated with TLR expression,
especially that of TLR3. Furthermore, infants with allergic
diseases have increased perinatal TLR3 responses (Prescott
et al., 2008). Upregulation of TLRs 2, 3, and 4 has also been
found in allergic rhinitis (Fransson et al., 2005). These findings
imply that TLR3 has important roles in enhancement of
allergic inflammation.
Allergic contact dermatitis (ACD) is a common allergic
inflammatory skin disease characterized by pruritic eczema-
tous lesions. Recent studies have shown that TLRs are involved
in the pathomechanism of ACD. TLR2 promotes a TH1
response by inducing interferon-g production from dendritic
cells in contact hypersensitivity (CHS; Jin et al., 2009). TLR4
has a crucial role in the development of CHS via immune
cells, including dendritic cells and natural killer T cells
(Askenase et al., 2005; Martin et al., 2008; Yokoi et al.,
2009). Epicutaneous immunization with protein antigen
induces suppression of subsequent CHS, but epicutaneous
application of protein antigen with TLR2, TLR3, TLR4, or TLR9
ligands reverses inhibition of CHS (Ptak et al., 2006; Majewska
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et al., 2009). Interestingly, recent reports suggest that hapten
sensitization can produce endogenous TLR ligands and can
activate innate immune responses, leading to skin inflam-
mation. For example, Ni2þ induces CHS by directly activating
human TLR4 (Schmidt et al., 2010; Martin et al., 2011),
whereas 2,4,6-trinitro-1-chlorobenzene (TNCB) and other
organic contact allergens activate TLR2 and TLR4 via
degradation of hyaluronic acid (Termeer et al., 2002;
Scheibner et al., 2006; Martin et al., 2008; Martin and
Jakob, 2008; Freudenberg et al., 2009; Martin et al., 2011).
These findings suggest that TLRs are deeply involved in the
pathogenesis of ACD. However, the function of TLR3 in skin
inflammation including ACD remains to be defined.
In the current study, we investigated the function of TLR3 in
inflammatory skin diseases. We first examined whether TLR3
signaling affects CHS using Toll-like receptor 3 knockout (Tlr3
KO) and transgenic (Tg) mice. We then investigated whether
TLR3 is involved in the sensitization and elicitation periods,
assessed the role of TLR3 in non-antigen-specific responses in
a mouse model of irritant contact dermatitis (ICD), and
evaluated possible roles of TLR3 signaling in cells that are
important in inflammatory skin diseases.
RESULTS
Inhibition of the CHS response in Tlr3 KO mice
We investigated the involvement of TLR3 in the CHS reaction
by measuring ear thickness after hapten challenge in wild-type
(WT), Tlr3 KO, and TLR3 Tg mice. TNCB was applied to the
abdominal skin a week before ear application. We previously
confirmed that TLR3 mRNA expression was greater in TLR3 Tg
mice than in WT mice and was undetectable in Tlr3 KO mice
(Ueta et al., 2009). Interestingly, the degree of ear swelling in
Tlr3 KO mice was significantly lower than that in WT mice at
24 hours (Figure 1a) and 48 hours (Supplementary Figure S1a
online) after TNCB challenge, whereas the ear-swelling
response in TLR3 Tg mice was greater than that in WT mice
(Figure 1a; Supplementary Figure S1a online). Histology of the
ear skin at 24 hours (Figure 1b) and 48 hours (Supplementary
Figure S1b online) after TNCB challenge showed extensive
leukocyte infiltration and edema in the dermis of WT mice.
Such reactions were substantially lower in the ear skin of Tlr3
KO mice than in WT mice. In contrast, greater leukocyte
infiltration and edema were observed in TLR3 Tg mice after
TNCB challenge than in WT mice (Figure 1b; Supplementary
Figure S1b online). Fewer inflammatory cells were observed in
Tlr3 KO mice after TNCB challenge than in control mice
(Figure 1c; Supplementary Figure S1c online), whereas more
inflammatory cells were observed in TLR3 Tg mice than in WT
mice (Figure 1c; Supplementary Figure S1c online). To
examine the irritant effects of TNCB, TNCB was topically
applied on the ear skin of nonsensitized mice. The results
showed almost no inflammation in the skin (Supplementary
Figure S2 online), indicating that TNCB has no strong effect on
the skin as an irritant. These findings suggest that TLR3
signaling is involved in the CHS response.
No requirement for TLR3 in the sensitization phase of the CHS
response
The CHS response consists of two phases: sensitization and
elicitation. To identify the action phase of TLR3, we first
examined the role of TLR3 in the sensitization period using an
adoptive transfer–induced CHS model. Lymph node cells were
isolated from regional lymph nodes of TNCB-sensitized Tlr3
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Figure 1. Impaired CHS response in Tlr3 KO mice. (a) Change in ear-swelling
responses of wild-type (WT; n¼ 12), Tlr3 knockout (KO; n¼ 6), and TLR3
transgenic (Tg; n¼11) mice. (b) Histologic examination of ear skin.
Hematoxylin and eosin. Original magnification  100. Bar¼ 50mm.
(c) Numbers of cells infiltrated in the dermis. Data are expressed as the
means±SD. **Po0.01. CHS, contact hypersensitivity.
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KO or WT mice, and adoptively transferred into naive WT
mice or immunodeficient NOD/ShiJic-scid JCl mice. Immedi-
ately after transfer, recipient mice were challenged with TNCB
on the ears. The degrees of ear swelling (Figure 2a; Supple-
mentary Figure S3a online) and the numbers of inflammatory
cells (Figure 2b and Supplementary Figure S3b online) did not
differ significantly between WT mice and Tlr3 KO mice as the
donors of lymph node cells. These results show that the
sensitization phase was not the action phase of TLR3.
Requirement for TLR3 in the elicitation phase of the CHS
response
We next assessed the possible role of TLR3 in the elicitation
period of CHS. When lymph node cells from sensitized WT
mice were transferred to naive Tlr3 KO or WT mice, the Tlr3
KO recipient mice showed significantly lower ear swelling
than the WT recipients (Figure 2a). The number of inflamma-
tory cells in Tlr3 KO mice was also lower than that in WT
mice (Figure 2b). These results show that TLR3 exerts its
function during the elicitation phase of the CHS reaction.
Inhibition of irritation response in Tlr3 KO mice
To investigate whether involvement of TLR3 depends on an
antigen-specific response, we examined the cutaneous
response after application of the irritant croton oil in WT,
Tlr3 KO, and TLR3 Tg mice. In contrast to ACD, ICD evolves
as a consequence of direct toxic effects of chemical agents
including croton oil and shows non-antigen-specific responses
(Corsini and Galli, 1998). Ear thickness was determined at
6 hours after topical application of croton oil. The degree of
ear swelling in Tlr3 KO mice was lower than that in WT mice,
whereas the ear-swelling response was greater in TLR3 Tg
mice than in WT mice (Figure 3a). Histology of the ear skin at
6 hours after croton oil application showed extensive leuko-
cyte infiltration and edema in the dermis of WT mice. The
degree of infiltration in the ear skin of Tlr3 KO mice was
significantly lower than that in Tlr3 KO mice. In contrast,
greater leukocyte infiltration and edema were observed in
TLR3 Tg mice than in Tlr3 KO mice (Figure 3b). The number of
inflammatory cells in Tlr3 KO mice was also lower than that in
WT mice (Figure 3c), whereas more inflammatory cells were
observed in TLR3 Tg mice than in WT mice (Figure 3c). These
results suggest that TLR3 is involved in ICD, as well as in ACD.
Unimpaired function of dendritic cells and lymphocytes
Dendritic cells and lymphocytes have a protagonistic role in
the pathogenesis of ACD (Sebastiani et al., 2002). To examine
the possible role of TLR3 in cutaneous dendritic cells in
inflammation, we examined the migration and maturation of
these cells after application of FITC on the shaved abdominal
skin of Tlr3 KO and WT mice. The numbers of FITCþ
CD11cþ , FITCþ CD86þ , and FITCþ MHC class IIþ
cutaneous dendritic cells accumulating in the lymph nodes
at 24 hours after FITC application in Tlr3 KO mice did not
differ significantly from those in WT mice (Figure 4a).
The lymphocyte stimulatory capacity of dendritic cells was
evaluated in a carboxyfluorescein succinimidyl ester (CFSE)–
staining assay. Lymph node cells of C57BL/6 mice were
incubated with allogeneic BALB/c WT or Tlr3 KO splenic
CD11cþ dendritic cells, and the fluorescence intensity of
CFSE-labeled lymph node cells was analyzed by flow cyto-
metry. The results showed no difference in the lymph node cell
proliferation rate between WT and Tlr3 KO mice (Figure 4b).
These results indicate that TLR3 did not affect migration,
maturation, and antigen presentation of dendritic cells.
Proliferation of lymphocytes in Tlr3 KO and WT mice was
also evaluated in a CFSE-staining assay. Lymph node cells of
BALB/c WT or Tlr3 KO mice were incubated with allogeneic
C57BL/6 splenic CD11cþ dendritic cells, and the fluores-
cence intensity of CFSE-labeled lymph node cells was ana-
lyzed by flow cytometry. There was no difference in the lymph
node cell proliferation rate between WT and Tlr3 KO mice
(Figure 4c). These results indicate that TLR3 expression did not
affect the lymphocyte proliferation function.
Cytokine and chemokine expression in the elicitation phase of
the CHS response
Cytokines and chemokines have important roles in the
elicitation of ACD and ICD. Therefore, we examined the
expressions of the cytokines and chemokines that are impor-
tant for the development of ACD and ICD in cutaneous tissue
of TNCB-induced CHS. Our results show that the expressions
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Figure 2. TLR3 is required for the elicitation phase of CHS, but not the
sensitization phase. Lymph node cells were prepared from sensitized wild-type
(WT) or Tlr3 knockout (KO) donors and adoptively transferred into naive WT or
Tlr3 KO recipients (n¼4–9 per group). (a) Change in ear-swelling responses at
24 hours after challenge. (b) Numbers of cells infiltrated in the dermis. Data are
expressed as the means±SD. *Po0.05; **Po0.01. CHS, contact
hypersensitivity; TNCB, 2,4,6-trinitro-1-chlorobenzene.
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of IL-1a, IL-1b, tumor necrosis factor (TNF)-a, interferon-g-
inducible protein 10 (IP-10), and regulated on activation,
normally T-cell expressed and secreted (RANTES) tended to be
elevated in the whole tissue of TNCB-treated ears in WT mice
compared with Tlr3 KO mice, although the differences of
IL-1a, TNF-a, and RANTES were not statistically significant
(Figure 5).
DISCUSSION
In this study, the CHS response was inhibited in Tlr3 KO mice
and enhanced in TLR3 Tg mice. The elicitation phase was the
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Figure 3. Impaired ICD response in Tlr3 KO mice. (a) Changes in ear-swelling
responses of wild-type (WT; n¼ 8), Tlr3 knockout (KO; n¼ 8), and TLR3
transgenic (Tg; n¼9) mice. (b) Histologic examination of ear skin.
Hematoxylin and eosin. Original magnification  100. Bar¼ 50mm.
(c) Numbers of cells infiltrated in the dermis. Data are expressed as the
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Figure 4. Comparison of DC and lymphocyte function between WT and Tlr3
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FITCþ CD11cþ DCs, FITCþ CD86þ , and FITCþ MHC class IIþ were
analyzed by flow cytometry 24 hours after FITC application (n¼3 per group).
(b) CD11cþ DCs prepared from spleen of WT or Tlr3 KO mice were incubated
with CFSE-labeled lymph node cells of C57BL/6 mice for 7 days (n¼ 3 per
group). (c) CFSE-labeled lymph node cells of WT or Tlr3 KO mice were
incubated with allogeneic CD11cþ DCs prepared from spleen of C57BL/6
mice for 7 days (n¼ 3 per group). The percentage of proliferating cells is
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knockout; WT, wild-type.
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major action phase of TLR3 in the CHS on the basis of the
results of adoptive transfer experiments of lymph node cells
from TNCB-sensitized animals. The ICD response was also
suppressed in Tlr3 KO mice and increased in TLR3 Tg mice.
Our results suggest that TLR3 has an important role in the
enhancement of skin inflammation in the elicitation phase of
ACD and in ICD.
In the sensitization phase of ACD, cutaneous dendritic cells
ingest hapten that has penetrated into the skin, migrate to
regional lymph nodes, and then present the antigens to naive
T cells. This process leads to the clonal expansion of antigen-
specific T cells that can be recruited to the skin. Recent studies
have shown that the activation of TLRs through the recognition
of pathogens or their products can induce maturation and
migration of dendritic cells and antigen-specific T-cell expan-
sion (Akira et al., 2001). TLR2 and TLR4 signaling is important
for dendritic cell function and the generation of effector T cells
in the sensitization phase of the CHS response (Martin et al.,
2008; Yokoi et al., 2009). Because dendritic cells and
lymphocytes express TLR3 (Applequist et al., 2002), we
expected possible involvement of these cells in TLR3-
dependent mechanisms of the CHS response. Therefore, we
investigated whether TLR3 signaling affects the sensitization
phase of the CHS response and the functions of dendritic cells
and lymphocytes. Our results of adoptive transfer experiments
of lymph node cells from TNCB-sensitized mice suggest that
the sensitization phase is not strongly related to TLR3
signaling. Furthermore, we found that the migration of
cutaneous dendritic cells to draining lymph nodes did not
decrease in Tlr3 KO mice compared with WT mice. Lack of
TLR3 expression also did not affect maturation and antigen
presentation of dendritic cells, and lymphocyte proliferation
induced by stimulation of antigen was not changed in Tlr3 KO
mice. These findings suggest that TLR3 in dendritic cells and
lymphocytes may not be closely associated with the
development of ACD and ICD.
The inflammatory responses in the elicitation phase of the
CHS depend on both antigen-dependent and antigen-inde-
pendent mechanisms (Grabbe and Schwarz, 1998; Honda
et al., 2013). Upon reexposure to haptens, antigen-specific T
cells are activated by cutaneous antigen-presenting cells,
produce numerous mediators, and induce activation of
several cell types in the skin. Haptens also directly activate
keratinocytes, in an antigen-nonspecific manner (Sebastiani
et al., 2002; Honda et al., 2013). These reactions also affect
each other, leading to the exacerbation of inflammation. In
this study, we indicate that TLR3 is associated with the
development of the elicitation phase of ACD and ICD. In
addition, our results show no significant difference of the
function of dendritic cells and lymphocytes between Tlr3 KO
and WT mice. Taken together, these findings suggest that TLR3
may be involved in antigen-independent cutaneous responses
in the elicitation phase of ACD and ICD.
Cytokines and chemokines are important mediators in the
elicitation phase of ACD and ICD. TNF-a, IL-1a, and IL-1b
have a crucial role in eliciting CHS and ICD (Corsini and
Galli, 1998; Watanabe et al., 2007). With regard to
chemokines, deficiency of IP-10 exhibits a reduced CHS
response (Dufour et al., 2002). Blocking the receptor
against RANTES decreases inflammatory responses in ACD
and ICD by inhibiting leukocyte recruitment (Canavese et al.,
2010). Administration of antibodies against keratinocyte
chemoattractant suppresses the CHS response via the
inhibition of neutrophil recruitment (Dilulio et al., 1999).
Our results show that the expressions of IL-1a, IL-1b, TNF-a,
IP-10, and RANTES tended to be elevated in the whole tissue
of TNCB-treated ears in WT mice compared with Tlr3 KO
mice, although the differences of IL-1a, TNF-a, and RANTES
were not statistically significant.
Resident skin cells, such as keratinocytes, fibroblasts, and
mast cells, have important roles in the recruitment of
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leukocytes to inflamed skin via the release of cytokines and
chemokines. Previous studies have shown that cytokines and
chemokines that are important for inflammatory responses are
secreted from epithelial cells and fibroblasts by stimulation
with poly(I:C) (Ueta et al., 2005; Kato et al., 2007; Ueta et al.,
2009; Farina et al., 2010; Ueta et al., 2010). Therefore, the
production of IL-1a, IL-1b, TNF-a, IP-10, and RANTES, which
tended to be elevated in the whole tissue of TNCB-induced
dermatitis in WT mice compared with Tlr3 KO mice, was
examined in poly(I:C)-stimulated primary cultures of
keratinocytes and dermal fibroblasts from WT mice and Tlr3
KO mice. Quantitative real-time PCR detected TLR3 in
primary keratinocytes from WT mice, but little TLR3 in those
from Tlr3 KO mice (data not shown). The production of IP-10
and RANTES was significantly increased in primary
keratinocytes and fibroblasts from WT mice after poly(I:C)
stimulation, but not in those from Tlr3 KO mice
(Supplementary Figures S4 and S5 online). In contrast, the
expression levels of IL-1a, IL-1b, and TNF-a mRNA were not
increased in primary keratinocytes and fibroblasts from WT
mice after poly(I:C) stimulation (data not shown). These
findings imply that keratinocytes and fibroblasts might release
mediators such as IP-10 and RANTES via TLR3 signaling,
leading to an increased CHS response.
Mast cells and macrophages also express TLR3 (Applequist
et al., 2002; Orinska et al., 2005) and contribute to the
pathogenesis of inflammatory skin diseases including CHS via
the production of various inflammatory mediators (Sebastiani
et al., 2002; Tuckermann et al., 2007). However, our results
showed no difference in degranulation of bone marrow–
derived mast cells between WT and Tlr3 KO mice (data not
shown). In addition, the defect of TLR3 did not affect the
phagocytic function and lymphocyte stimulatory capacity of
macrophages (data not shown). Therefore, TLR3 in mast cells
and macrophages may not mainly be related to inflammatory
responses.
Our results showed that TLR3 affected skin inflammation
in the absence of an exogenous viral pathogen. TLRs
recognize endogenous danger signals associated with tissue
damage (Seong and Matzinger, 2004; Tsan and Gao, 2004),
and recent studies have suggested that RNA released from
necrotic cells such as damaged keratinocytes (Lai et al.,
2009; Zhang et al., 2011; Bernard et al., 2012) and
neutrophils (Cavassani et al., 2008) might serve as a ligand
for TLR3 in various cell types, including keratinocytes
(Kariko´ et al., 2004; Cavassani et al., 2008; Lai et al.,
2009; Zhang et al., 2011; Bernard et al., 2012). Bernard
et al. (2012) demonstrated that UV-damaged self-RNAs or
UV-damaged keratinocytes are detected by TLR3.
Furthermore, UVB irradiation increases cytokine
production in the skin tissue and affects the CHS response
in a TLR3-dependent manner. Previous electron microscopic
studies demonstrated that necrosis of epidermal
keratinocytes and Langerhans cells is seen in ACD and
ICD (Willis et al., 1986; Willis et al., 1989). Therefore, RNA
released from cells damaged by an inflammatory stimulus
may activate TLR3 in keratinocytes and dermal fibroblasts in
ACD and ICD. However, the endogenous TLR3 ligands are
unknown in the mouse models of ACD and ICD. We are
currently studying the mechanisms of cutaneous inflam-
matory responses regulated by endogenous TLR3 ligands.
In conclusion, our data show that TLR3 enhances antigen-
independent skin inflammation and imply the possible invol-
vement of mediators released from resident skin cells in the
development of skin inflammation via TLR3 signaling.
MATERIALS AND METHODS
Mice
Male BALB/c and C57BL/6 mice and NOD/ShiJic-scid JCl mice were
obtained from Shimizu Laboratory Supplies (Kyoto, Japan) and CLEA
(Tokyo, Japan), respectively, and used at the age of 6–8 weeks. Male
Tlr3 KO and TLR3 Tg mice were generated as previously described
(Yamamoto et al., 2003; Negishi et al., 2008), back-crossed more
than seven generations to BALB/c mice (Ueta et al., 2009), and used
at the age of 6–8 weeks. All mice were housed in a specific pathogen-
free barrier facility and screened regularly for pathogens. This
experimental procedure was approved by the Committee for Animal
Research, Kyoto Prefectural University of Medicine.
Induction of ACD with TNCB
Mice were sensitized by application on the shaved abdominal skin of
25ml of 1% (w/v) TNCB in acetone/olive oil (4:1) or 25ml of vehicle
alone. At 7 days after sensitization, 20ml (10ml on the dorsal side and
10ml on the ventral side) of 1% TNCB was applied to the right ear.
The same amount of acetone/olive oil (4:1) was administered to the
left ear as a control. Ear thickness was measured at a predetermined
site with a dial thickness gauge (Shinwa Rules, Niigata, Japan). The
ear-swelling response was measured before elicitation and at 24 and
48 hours after elicitation and defined as the difference in ear thickness
before and after elicitation.
Induction of ICD with croton oil
Mice received topical application of 20ml of 2% (v/v) croton oil
(Sigma-Aldrich, St Louis, MO) in acetone/olive oil (4:1) to the dorsal
and ventral sides of the right ear. The same amount of acetone/olive
oil (4:1) was administered to the left ear as a control. The ear-swelling
response was measured before and 6 hours after elicitation and
defined as the difference in ear thickness before and after application.
Statistical analysis
All data are expressed as means±SD. Statistical significance was
assessed using one-way analysis of variance followed by a Tukey’s
multiple comparison test. A Student’s t-test was used for comparison
of mRNA expression in primary keratinocytes and fibroblasts.
A P-value o0.05 was considered significant in all analyses.
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